Back to Search
Start Over
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
- Source :
- The Lancet Respiratory Medicine; July 2020, Vol. 8 Issue: 7 p709-716, 8p
- Publication Year :
- 2020
-
Abstract
- Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of eligible individuals. Blood signatures might act as a standalone screening tool, refine the selection of patients at risk, or help to classify undetermined nodules detected on LDCT. We previously showed that circulating tumour cells (CTCs) could be detected, using the isolation by size of epithelial tumour cell technique (ISET), long before the cancer was diagnosed radiologically. We aimed to test whether CTCs could be used as a biomarker for lung cancer screening.
Details
- Language :
- English
- ISSN :
- 22132600 and 22132619
- Volume :
- 8
- Issue :
- 7
- Database :
- Supplemental Index
- Journal :
- The Lancet Respiratory Medicine
- Publication Type :
- Periodical
- Accession number :
- ejs53723777
- Full Text :
- https://doi.org/10.1016/S2213-2600(20)30081-3